Remove 2020 Remove Communication Remove Labelling
article thumbnail

RFID: The future of smart labelling?

Pharmaceutical Technology

In 2020, Fresenius Kabi introduced their first RFID-enabled medication, Diprivan +RFID. What lies ahead for RFID and smart labelling Volpe says “the future is bright” for smart technologies that identify, monitor, and track medications through the supply chain.

Labelling 105
article thumbnail

What They Said – A Look Back at FDA Press Releases First Half of 2020

Eye on FDA

But it is not likely to surprise anyone that the first half of 2020 has caused not only an increase in communication from FDA, but a focus as well. Approvals – There were 54 press statements regarding approvals so far in 2020, comparing to 42 approvals announced in 2019. Photo by AbsolutVision on Unsplash.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Scientific Communication for Pharma Marketing – Quiz

PharmaState Academy

Scientific Communication for Pharma Marketing - Quiz Competition Participate in the Quiz & learn more about the “Scientific Communication for Pharma Marketing” which is significant to Pharma Marketing & Sales professionals. Winner Prize: The Quiz winner will be awarded Amazon Gift card worth Rs.

article thumbnail

FDA’s Revised Draft Guidance on Biological Product Promotion Provides Additional Recommendations/Clarifications

FDA Law Blog: Biosimilars

Promotional labeling is generally any labeling other than FDA-required labeling that is devised for the promotion of a product, as well as other functions, and can include printed, audio, or visual matter that describes the product. l)(1) (e.g.,

article thumbnail

FDA-Approved Labeling: Is Enough Enough?

FDA Law Blog: Biosimilars

Livornese — I saw the sign…and the answer is no—FDA-approved labeling apparently is not enough under state failure-to-warn laws, according to certain courts. Most OTC drugs, particularly drugs that have been around for a while, are primarily marketed pursuant to OTC monographs.

article thumbnail

It Finally Happened – FDA’s OPDP Issues First Letter of 2023

Eye on FDA

It was the second letter for this company, the first having been issued in August, 2020 for a TV advertisement. The label for the medicine includes a boxed warning regarding potential issues related to complications for the liver (toxicity) and heart (QT prolongation). Of those 17 letters issued, 8 had boxed warnings.

article thumbnail

Can holograms help in the frontline fight against pharmaceutical counterfeiting?

European Pharmaceutical Review

Indeed, a 2020 operation coordinated by Europol across 27 countries led to the seizure of more than 25 million units of counterfeit anticancer drugs and erectile dysfunction medicines among other fake drugs worth nearly €73 million. Elsewhere, holographic labels have been deployed effectively to arrest declining sales of pharmaceuticals.

Packaging 111